STOCK TITAN
  1. Home
  2. Sec-filings
  3. GEHC
  4. [Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

GEHC Form 4: 10,217 restricted stock units granted to officer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kenneth R. Stacherski, an officer of GE HealthCare Technologies Inc. (GEHC), was awarded 10,217 restricted stock units (RSUs) on 08/15/2025. Each RSU converts to one share of GE HealthCare common stock at settlement. The award vests 50% on 08/15/2027 and 50% on 08/15/2028. Following the grant, the reporting person beneficially owns 41,888 shares. The Form 4 was signed by the company General Counsel as attorney-in-fact on 08/19/2025. No derivative transactions or cash purchase price were reported for this grant.

Positive

  • Award recorded: Grant of 10,217 restricted stock units reported on 08/15/2025
  • Clear vesting schedule: 50% vesting on 08/15/2027 and 50% vesting on 08/15/2028
  • Updated ownership disclosed: Beneficial ownership reported as 41,888 shares

Negative

  • None.

Insights

TL;DR: Officer received a time-based RSU grant of 10,217 units with two-year cliff vesting schedule, increasing reported beneficial ownership to 41,888 shares.

This filing documents a standard equity-based compensation award. The grant is time-vested with 50% vesting on August 15, 2027 and the remaining 50% on August 15, 2028, which is a typical multi-year retention structure. The report shows no exercise price or cash payment because these are restricted stock units settled in shares. For governance review, the filing confirms insider ownership levels and the timetable for potential share delivery, important for alignment and blackout planning.

TL;DR: Form 4 discloses a routine equity award by an officer; transaction code indicates an acquisition through compensation.

The document indicates the transaction code for acquisition and specifies that each RSU equals one share at settlement. The Form 4 lists the reporting person as an officer and shows the updated beneficial ownership of 41,888 shares. There are no derivative positions, no cash consideration, and the signature was executed by the General Counsel as attorney-in-fact. From a compliance perspective, the filing meets Section 16 disclosure of an insider award and establishes the vesting schedule for future reporting triggers.

Insider Stacherski Kenneth R.
Role Chief Enterprise Oper. Officer
Type Security Shares Price Value
Grant/Award Common Stock, par value $0.01 per share 10,217 $0.00 --
Holdings After Transaction: Common Stock, par value $0.01 per share — 41,888 shares (Direct)
Footnotes (1)
  1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on August 15, 2027, and 50% will vest on August 15, 2028. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stacherski Kenneth R.
(Last) (First) (Middle)
500 W. MONROE STREET
(Street)
CHICAGO IL 60661
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Enterprise Oper. Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 08/15/2025 A 10,217(1)(2) A $0 41,888 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on August 15, 2027, and 50% will vest on August 15, 2028.
2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did GEHC insider Kenneth R. Stacherski receive on 08/15/2025?

He was awarded 10,217 restricted stock units (RSUs), each representing the right to receive one share of GE HealthCare common stock.

When do the RSUs granted to the GEHC officer vest?

The RSUs vest 50% on August 15, 2027 and 50% on August 15, 2028.

How many GEHC shares does the reporting person beneficially own after the grant?

The Form 4 reports beneficial ownership of 41,888 shares following the transaction.

Was there any cash price reported for the RSU grant on the Form 4?

No cash price was reported; the transaction shows acquisition of RSUs with a reported price of $0 for the units.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact on 08/19/2025.